Halozyme Therapeutics, Inc. (NASDAQ:HALO – Get Free Report) Director Matthew L. Posard sold 10,000 shares of the firm’s stock in a transaction dated Tuesday, June 11th. The stock was sold at an average price of $50.01, for a total value of $500,100.00. Following the completion of the transaction, the director now directly owns 109,755 shares […]
Several analysts have recently updated their ratings and price targets for Insmed (NASDAQ: INSM): 6/7/2024 – Insmed had its price target raised by analysts at Mizuho from $36.00 to $82.00. They now have a “buy” rating on the stock. 5/31/2024 – Insmed had its price target raised by analysts at Stifel Nicolaus from $39.00 to […]
Halozyme Therapeutics, Inc. (NASDAQ:HALO – Get Free Report) Director Matthew L. Posard sold 10,000 shares of the firm’s stock in a transaction dated Tuesday, June 11th. The stock was sold at an average price of $50.01, for a total value of $500,100.00. Following the completion of the transaction, the director now directly owns 109,755 shares […]
Zillow Group, Inc. (NASDAQ:ZG – Get Free Report) Director Jay C. Hoag purchased 1,000,000 shares of the firm’s stock in a transaction that occurred on Friday, June 7th. The stock was bought at an average price of $42.27 per share, for a total transaction of $42,270,000.00. Following the purchase, the director now owns 652,520 shares […]
Zillow Group, Inc. (NASDAQ:ZG – Get Free Report) Director Jay C. Hoag bought 816,866 shares of the stock in a transaction that occurred on Monday, June 10th. The shares were bought at an average cost of $43.14 per share, with a total value of $35,239,599.24. Following the completion of the purchase, the director now directly […]